筋弛緩薬の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Muscle Relaxant Drugs Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
• Key market highlights

PART 05: An overview of muscle spasticity and spasms

PART 06: Pipeline landscape

PART 07: Market landscape
• Market overview
• Five forces analysis

PART 08: Market segmentation by product category
• Skeletal muscle relaxant drugs
• Facial muscle relaxant drugs

PART 09: Geographical segmentation
• Muscle relaxant drugs market in Americas
• Muscle relaxant drugs market in EMEA
• Muscle relaxant drugs market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges
• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 12: Market trends
• Anti-aging treatments driving adoption of facial relaxants
• Advanced drug delivery technologies fuels adoption of muscle relaxants
• Growing use of muscle relaxants in new indications and applications

PART 13: Vendor landscape
• Competitive scenario

PART 14: Key vendor analysis
• Pfizer
• Allergan
• Ipsen Group
• Teva Pharmaceuticals
• Novartis
• Other prominent vendors

PART 15: Appendix
• List of abbreviations

[List of Exhibits]

Exhibit 01: Key muscle relaxants
Exhibit 02: Pipeline landscape
Exhibit 03: Global muscle relaxant drugs market snapshot
Exhibit 04: Global muscle relaxant drugs market 2016-2021 ($ millions)
Exhibit 05: Opportunity analysis in global muscle relaxant drugs market
Exhibit 06: Five forces analysis
Exhibit 07: Global muscle relaxant drugs market by product category 2016
Exhibit 08: Global skeletal muscle relaxant drugs market 2016-2021 ($ millions)
Exhibit 09: Global facial muscle relaxant drugs market 2016-2021 ($ millions)
Exhibit 10: Global muscle relaxant drugs market by geography 2016 and 2021
Exhibit 11: Global muscle relaxant drugs market revenue by geography 2016-2021 ($ millions)
Exhibit 12: Market scenario in Americas
Exhibit 13: Muscle relaxant drugs market in Americas 2016-2021 ($ millions)
Exhibit 14: Market scenario in EMEA
Exhibit 15: Muscle relaxant drugs market in EMEA 2016-2021 ($ millions)
Exhibit 16: Market scenario in APAC
Exhibit 17: Muscle relaxant drugs market in APAC 2016-2021 ($ millions)
Exhibit 18: Key approvals for new indications
Exhibit 19: Key factors driving the market growth
Exhibit 20: Impact of drivers
Exhibit 21: Impact of challenges
Exhibit 22: Competitive structure analysis of global muscle relaxant drugs market 2016
Exhibit 23: Competitive analysis of global muscle relaxant drugs market
Exhibit 24: Strategic success factors of companies in global muscle relaxant drugs market
Exhibit 25: Pfizer: Strength assessment
Exhibit 26: Pfizer: Strategy assessment
Exhibit 27: Pfizer: Opportunity assessment
Exhibit 28: Allergan: Key highlights
Exhibit 29: Allergan: Strength assessment
Exhibit 30: Allergan: Strategy assessment
Exhibit 31: Allergan: Opportunity assessment
Exhibit 32: Ipsen Group: Key highlights
Exhibit 33: Ipsen Group: Strength assessment
Exhibit 34: Ipsen Group: Strategy assessment
Exhibit 35: Ipsen Group: Opportunity assessment
Exhibit 36: Teva Pharmaceuticals: Strength assessment
Exhibit 37: Teva Pharmaceuticals: Strategy assessment
Exhibit 38: Teva Pharmaceuticals: Opportunity assessment
Exhibit 39: Novartis: Strength assessment
Exhibit 40: Novartis: Strategy assessment
Exhibit 41: Novartis: Opportunity assessment


【レポート販売概要】

■ タイトル:筋弛緩薬の世界市場2017-2021
■ 英文:Global Muscle Relaxant Drugs Market 2017-2021
■ 発行日:2017年3月7日
■ 調査会社:Technavio
■ 商品コード:IRTNTR12170
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。